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Abstract
Aminolevulinic Acid (ALA)-induced Protoporphyrin IX (PpIX) fluorescence was studied as a
contrast agent for noninvasive detection of murine glioma, using the fluorescence to transmission
ratio measured through the cranium. Signal measured prior to administration of ALA was very similar
between control animals, 9L-GFP and U251 tumor-bearing animals. However, 2 hours after ALA
administration, the PpIX signal from both tumor-bearing groups was significantly higher than the
control group (9L-GFP group p-value = 0.016, and U251 group p-value = 0.004, relative to control
group). The variance in signal from the 9L-GFP group was much larger than either the control group
or the U251 group, which was consistent with higher intrinsic PpIX fluorescence heterogeneity as
seen in situ at ex vivo analysis. Decreasing the skin PpIX fluorescence via intentional photobleaching
using red light (635 nm) was examined as a tool for increasing PpIX contrast between the tumor-
bearing and control groups. The red light bleaching was found to increase the ability to accurately
quantify PpIX fluorescence in vivo, but decreased the specificity of detection between tumor-bearing
and non-tumor-bearing groups.
INTRODUCTION
Aminolevulinic acid (ALA), the precursor to protoporphyrin IX (PpIX) has been under
extensive study as a photosensitizer for photodynamic therapy (PDT) and for photodiagnosis
(PD) in oncology for over 20 years [1]. While much of the focus with ALA detection of tumors
has been in thin squamous tissues, perhaps one of the most successful applications of ALA-
PpIX for fluorescence visualization, and certainly the most important to the work presented
here, has been use of ALA-induced PpIX for surgical guidance of brain tumor resection due
to demonstration of high PpIX signal in the tumor tissue as compared to the normal brain [2–
4]. The use of this contrast agent to detect tumors noninvasively has seen little study, yet
transmission of the fluorescence through bulk tissue up to several centimeters is readily
feasible. With post processing of the signal to normalize for attenuation and provide spectral
filtering to remove background, it is feasible to develop noninvasive tools for detection of
tumors and tracking the production of PpIX at the tissue surface for a variety of orthotopic
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murine tumors both implanted and of transgenic origin. This study has focused on these aspects
of the problem in the context of murine glioma.
Administration of ALA overloads the heme synthesis pathway, which exists in all mammalian
cells, and fluorescently detectable levels of PpIX are produced [5–7]. ALA-induced PpIX is
now used extensively in dermatologic applications, with approval for treatment of actinic
keratosis in the US in 1999 [8]. Methyl-Aminolevulinic acid (MAL), an ester derivative of
ALA, has been approved in Europe for treatment of skin lesions [8]. One confounding factor
in detection is the heterogeneity of PpIX production between tumor sub-types and even within
an individual tumor. PpIX production levels between various tumor lines in vitro have been
found to be quite heterogeneous [9], however most brain tumor cell lines are known to have
higher PpIX production than normal brain cells [10–12], indicating that there is likely always
positive contrast relative to normal brain. This data agrees with ALA-induced PpIX
fluorescence in vivo in preclinical models as well as clinical data, where significant differences
in tumor tissue removal can be achieved through fluorescence guided surgery over
conventional white light surgery [2,13].
Extensive study on human glioma patients has been completed by Stummer, et al culminating
in a multicenter clinical trial where ALA-induced PpIX fluorescence guided resection of human
gliomas was compared to conventional white light resection. The contrast-enhancing portion
of the tumor, as detected by magnetic resonance imaging, was completely removed in 65% of
the fluorescence guided resections as compared to 36% of the white light surgeries. This
increased 6 month progression free survival to 41% in the fluorescence guided resection group
as compared to 21.1% in the white light resection group [13]. The ability to visualize PpIX
fluorescence in brain tumor tissue over normal brain tissue via surgical guidance was
motivating for this work on noninvasive detection of brain tumors due to high tumor to normal
brain tissue PpIX fluorescence signals.
Following earlier studies completed in vitro [9], PpIX fluorescence was explored for its ability
to delineate tumor-bearing animals from healthy animals in a noninvasive manner.
Transmission fluorescence spectroscopy was used for noninvasive detection of PpIX
fluorescence, while normalizing the signal to the transmitted excitation light signal [14]. Even
through use of this transmission geometry, the PpIX fluorescence signal from the mouse skin
was found to influence measurements, so skin photobleaching was explored as a method to
increase PpIX signal contrast between tumor-bearing animals and healthy animals [15–17].
MATERIALS AND METHODS
Cell Culture
Two cell lines were used in the studies presented; the 9L rat gliosarcoma cell line which had
been transfected with green fluorescent protein (9L-GFP) and the human glioma cell line U251.
The 9L-GFP cell line was a generous gift from Alexi Bogdanov [18]. The cell lines were
cultured in Dulbecco’s Modification of Eagle’s Medium (Cellgro, Mediatech, Herndon, VA)
supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA) and 1%
penicillin/streptomycin from a stock solution of 10,000 IU penicillin and 10,000 µg/ml
streptomycin (Mediatech, Inc., Herndon, VA), and were kept incubated at 37° Celsius in a 95%
air and 5% carbon dioxide humidified environment.
Murine Glioma Model
Both cell lines (9L-GFP and U251) were used for intracranial implantation into male athymic
nude mice about 6 weeks of age. Mice were anesthetized using ketamine/xylazine in a 90:10
mg/kg ratio and their body temperature was maintained during anesthesia via a heating pad. A
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small incision was made in the scalp exposing the top of the skull so that the landmarks on the
brain were visible. A Dremel drill was used to make a 1 mm hole in the skull, located 2 mm
in front of the bregma and 2 mm to the left of the midline, after which the needle was inserted
2 mm deep into the brain via guidance from a sterotactic frame. A total of 1×106 cells in 10 µl
of phosphate buffered saline (PBS) were injected over 5 minutes using a Hamilton syringe.
After the injection, the needle was slowly retracted, the skull was cleaned to ensure cells were
not deposited outside the brain and bone wax was used to cover the hole drilled in the skull.
Finally, the incision in the scalp was closed with a small amount of Vetbond Tissue Adhesive
(J.A. Webster, Inc, Sterling, MA). Mice were examined daily following surgery to ensure
proper healing of the scalp. Control mice were implanted with 10 µl PBS without cells to allow
similar surgical procedures to be performed on all mice.
Single Channel Fluorescence Spectroscopy System
A schematic of the single channel spectroscopy system can be seen in figure 1(a). The system
consisted of a 250 mW, 635 nm diode laser (Power Technology, Inc.) for excitation collimated
onto the chin of the mouse. The light transmitted through the mouse head was collected through
a second collimator, and passed through a 650 nm LP filter prior to spectrally resolved detection
through a spectrometer (1200 l/mm grating, SpectraPro 300, Acton Research, Acton MA) and
onto a cooled CCD camera (Spec-10:400BR/XTE, Princeton Instruments, Acton MA). Data
from the camera was captured and transferred using commercial software (Winspec, Acton
Research). The spectrometer was centered at 705 nm to collect the PpIX fluorescence emission
peak and at 615 nm to collect the transmitted intensity from the 635 nm laser. A mouse holder
consisted of a bed in a light tight box with holes 180° apart from one another to hold the
collimators, for collection of spectroscopy data (Figure 1(b) & 1(c)).
Spectroscopy Data Collect & Processing
At each time point the mouse was placed in the mouse holder with the collimators in contact
with the head. Fluorescence emission data was collected with the spectrometer centered at 705
nm and the exposure time adjusted to obtain signals in the linear range of the spectrometers
with maximal signal to noise level. The light was passed through the 650 nm LP filter to collect
the PpIX fluorescence emission prior to detection by the spectrometer (figure 2(a)). Prior to
any movement of the mouse, transmittance data was also collected, where the spectrometer
was centered at 615 nm to allow detection of the 635 nm laser intensity through the 650 nm
LP filter and the exposure time was again adjusted to ensure detection in the linear range of
the spectrometers (figure 2(b)).
The raw spectral excitation and emission data were post-processed by a two-step process
involving spectral fitting and then normalization. PpIX fluorescence data was collected using
a liquid tissue simulating phantom composed of 1% Intralipid to simulate scattering, 1 mg/L
India ink to simulate absorption, 1 µg/mL PpIX in dimethyl sulfoxide to simulate in vivo PpIX
concentrations and 5% Tween 20 to decrease aggregation of PpIX, a hydrophobic molecule,
in solution. The spectral shapes of PpIX obtained from these tissue simulating phantoms were
normalized to one and used for spectral fitting of in vivo PpIX data. The fluorescence data was
spectrally fitted using a MatLab program to perform a linear least squares fit to the PpIX
phantom data, so that the non-specific background signal could be deconvolved from the PpIX
fluorescence signal (figure 2(c) & 2(d)), as it had a distinctly different spectral shape. The area
under the deconvolved PpIX fluorescence curve was than calculated and reported as a single
number. Both the fluorescence emission data and the transmittance data were normalized to
counts/second to account for differences in exposure time. Then the integrated fluorescence
intensity was normalized to the integrated transmitted laser intensity to account for positional
differences between measurements of a single mouse as well as variations in optical properties
[14], resulting in the fluorescence to transmittance ratio.
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PpIX Detection of Brain Tumors
At 10 – 14 days after tumor implantation, the mice were imaged via a large bore Philips 3T
Magnetic Resonance Imaging (MRI) Achieva system, using a modified rodent body coil insert
[19]. A plastic insert was used in the rodent coil to raise the mouse into the isocenter of the
magnetic field (Figure 3(a) & 3(b)). Intracranial tumors were identified using T1 turbo spin
echo (TSE) images with and without Gadolinium enhancement (1 µl/mg body weight) (figure
3(c)) as well as T2 TSE imaging sequences. T1 TSE and T2 TSE images were also collected
prior to sacrifice for in vivo and ex vivo tumor comparison.
Prior to ALA administration the mice were placed in the single channel spectroscopy mouse
holder and their background PpIX fluorescence was measured while they were under inhaled
isofluorane anesthesia. The mice were then administered 100 mg/kg ALA dissolved in PBS
by intraperitonal (IP) injection. Two hours after ALA administration, the PpIX fluorescence
was again measured using the single channel spectroscopy system. The mice were then
sacrificed, their brains extracted and placed back into the spectroscopy system for ex vivo
measurement of the tumor in situ. Following collection of all spectroscopy measurements, the
brain was sectioned in a coronal plane and imaged on a fluorescence plate scanner (Typhoon
9410, GE Healthcare Life Sciences) with the cut faces of the brain facing the imaging plane
of the scanner. The tissue slices were imaged for PpIX fluorescence using a 633 nm excitation
laser and a 650 nm LP emission filter, and when appropriate then scanned for GFP fluorescence
using a 488 nm laser with a 526 nm SP emission filter. Following fluorescence imaging, the
brain slices were sent to pathology for routine H+E staining.
Red Light Time Course Photobleaching
Four control mice, nine 9L-GFP tumor-bearing mice and seven U251 tumor-bearing mice were
compared in this study. In each group the tumors were implanted, identified via MRI and the
PpIX fluorescence of each mouse was then measured using the single channel spectroscopy
system as described previously. Following the measurement 2 hours after the administration
of ALA, the 635 nm laser was left running and subsequent measurements were collected after
1, 2, 4, 8, 16, 24 and 32 minutes to allow for photobleaching of the skin PpIX fluorescence
signal.
Statistical Analysis
Differences between all groups were established through box and whisker plots and unpaired
2-tailed students-t tests to establish p-values for comparison of all groups of interest. All box
and whisker plots shown illustrate the median as the center line and the interquartile range as
the shaded box showing 75% of the data. The upper whisker represents Q3 + 1.5(Q3 − Q1)
and the lower whisker represents Q1 − 1.5(Q3 −Q1), where Q is the quartile. Each open circle
represents the fluorescence to transmittance ratio of one mouse.
The ability to quantify PpIX fluorescence spectroscopy as a method to detect tumors was
assessed by receiver operator characteristic (ROC) analysis. The values for sensitivity and
specificity were estimated based upon the number of true positives, false positives, true
negatives and false negatives, where tumor status was confirmed through MRI and histology.
Sensitivity was calculated as the number of true positive (TP) cases divided by the number of
true positive and false negative (FN) cases (Sensitivity = TP/(TP + FN)). Specificity was
calculated as the number of true negative cases (TN) divided by the number of true negative
and false positive (FP) cases (Specificity = TN/(TN + FP)) [20].
ROC curves were constructed using different intensity threshold levels on the PpIX
fluorescence to transmittance ratio collected from the control, 9L-GFP and U251 tumor-
bearing mice. As the intensity threshold was changed the true positive fraction (TPF) and false
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positive fraction (FPF) were calculated, where TPF is synonymous with sensitivity and FPF
is representative of 1 minus the specificity of the tumor detection modality. The area under the
curve (AUC) was calculated from the ROC curves and used as a direct measure of sensitivity
and specificity of the spectroscopy system for tumor detection. An AUC of 1 would indicate
that the tumor detection modality had 100% sensitivity and specificity of detection while an
AUC of 0.5 would indicate there was only 50% sensitivity and specificity, equivalent to random
guessing of tumor status.
RESULTS
PpIX Fluorescence Detection of Brain Tumors
At 18 – 22 days following tumor implantation the mice were measured in the single channel
spectroscopy system prior to ALA administration, 2 hours after ALA administration and ex
vivo following brain extraction. As can be seen in Figure 4(a), prior to the administration of
ALA the mean PpIX fluorescence of the control mice, 9L-GFP and U251 tumor-bearing mice
were very similar. However, 2 hours after the administration of ALA there was a significant
difference between the means of the control group and the 9L-GFP tumor-bearing group (p-
value = 0.016) as well as between the means of the control group and the U251 tumor-bearing
group (p-value = 0.004). The mean PpIX fluorescence of the 9L-GFP and U251 groups were
similar 2 hours after ALA administration, however the variance of the 9L-GFP group was large
compared to that of the U251 group (Figure 4(b)). Following sacrifice, ex vivo measurements
were collected on the bulk brain tissue. As can be seen in figure 4(c), the mean fluorescence
of the 9L-GFP group was slightly higher than that of the control group while the mean
fluorescence of the U251 group was significantly higher than either the control group (p-value
< 0.0001) or the 9L-GFP group (p-value = 0.021).
PpIX Tumor Tissue Production Heterogeneity
PpIX production following ALA administration was heterogeneous between mice as can be
seen in figure 5, which shows three sample 9L-GFP tumor-bearing mice. For each mouse the
same brain section is shown in a PpIX fluorescence image, a GFP fluorescence image and an
H+E stained image. Approximately the same section can be viewed in vivo via the T1 turbo
spin echo (TSE) Gadolinium contrast enhanced MR image. Figure 5 illustrates that while some
of the 9L-GFP mice showed PpIX production in the bulk tumor, as can be seen in Figure 5(a),
most of the 9L-GFP mice only had PpIX fluorescence on the periphery of the tumor tissue and
virtually no increase in PpIX fluorescence in the bulk tumor tissue over the surrounding normal
brain tissue (Figure 5(b) & 5(c)). The pattern of tumor tissue PpIX production in the 9L-GFP
gliosarcoma model was very different from that seen in the U251 glioma model. Figure 6 shows
that the PpIX production in the U251 tumors was confined to the bulk tumor when compared
to the H+E stained section in all three examples. It can also be seen that the T1 TSE Gadolinium
enhanced MR images and T2 TSE MR images allowed for in vivo visualization of
approximately the same tumor tissue section shown ex vivo.
Red Light Time Course Photobleaching
Due to high PpIX production in skin tissue, selective photobleaching of skin PpIX fluorescence
should improve noninvasive tumor tissue detection. The mean PpIX fluorescence measured 2
hours after ALA administration showed a different relationship between the control group and
the two tumor bearing groups than that seen by ex vivo PpIX measurements. Specifically, the
2 hour in vivo measurements showed the 9L-GFP group with slightly higher mean PpIX
fluorescence than the U251 group (mean PpIX fluorescence: control = 25.02, 9L-GFP = 43.20,
U251 = 41.50) as can be seen in Figure 4(b), while the ex vivo measurements illustrated that
the mean PpIX fluorescence of the U251 group was more than twice that of the 9L-GFP group
(mean PpIX fluorescence: control = 0.85, 9L-GFP = 3.3, U251 = 6.9) as reported in Figure 4
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(c). The time course photobleaching measurements were examined to determine if the red light
photobleaching facilitated in vivo visualization of the same PpIX fluorescence contrast pattern
seen in ex vivo measurements.
A similar relationship to that seen 2 hours after the administration of ALA was seen after 1, 2
and 4 minutes of red light photobleaching where the mean PpIX fluorescence of the 9L-GFP
group was slightly higher than that of the U251 group. The measurement obtained after 8
minutes of red light photobleaching showed the mean PpIX fluorescence of the U251 group
was higher than in the 9L-GFP group, which was the same relationship that was seen in the
ex vivo measurements. Box and whisker plots that showed the individual mice in each group
as well as the interquartile range can be seen in Figure 7 for the mice after 1, 2, 4 and 8 minutes
of red light photobleaching. The measured PpIX fluorescence of the 9L-GFP group was
considerably reduced following 8 minutes of red light photobleaching, the mean of which was
lower than the U251 group (mean PpIX fluorescence: control = 19.92, 9L-GFP = 27.24, U251
= 33.38).
Receiver Operator Characteristic (ROC) Analysis
Detection of tumor-bearing animals over non-tumor-bearing control animals via ALA-induced
PpIX fluorescence spectroscopy before and after red light photobleaching was assessed by
ROC analysis. ROC curves were plotted for each tumor type relative to the control animals 2
hours after ALA administration, but prior to any photobleaching (Figure 8(a)) and after 8
minutes of red light photobleaching (Figure 8(b)). Two hours after ALA administration, prior
to any photobleaching, the U251 tumor-bearing group could be detected with higher sensitivity
and specificity than the 9L-GFP tumor-bearing group as compared to the control group (U251
AUC = 0.94, 9L-GFP AUC = 0.72). Following the 8 minutes of red light photobleaching,
detection sensitivity and specificity were decreased in both tumor-bearing groups over the
control group, however the decrease was more significant in the 9L-GFP tumor-bearing group
than in the U251 tumor-bearing group. This decrease in detection sensitivity could be attributed
to increased overlap between the PpIX fluorescence to transmittance ratio of the tumor-bearing
group and the control group (U251 AUC = 0.92, 9L-GFP AUC = 0.69).
DISCUSSION
Two brain tumor lines which had very different tissue PpIX production patterns were studied
in vivo. The 9L-GFP and U251 tumor lines were examined for ability to detect brain tumor
presence noninvasively via spectroscopic measurements of PpIX fluorescence. Prior to the
administration of ALA, tumor-bearing mice could not be distinguished from control mice via
in vivo PpIX spectroscopy measurements (Figure 4(a)). At 2 hours after ALA administration,
the average PpIX fluorescence in both tumor-bearing groups was significantly higher than in
the control group (p-value 9L-GFP = 0.016, p-value U251 = 0.004 relative to control). Thus,
on average a tumor-bearing mouse could be detected over a normal mouse by noninvasive in
vivo PpIX spectroscopy measurements (Figure 4(b)). ROC analysis revealed detection
sensitivity and specificity were significantly higher for the U251 group (AUC = 0.94) than for
the 9L-GFP group (AUC = 0.72) (Figure 8(a)). This difference in PpIX fluorescence between
the tumor-bearing groups and the control group was confirmed through ex vivo PpIX
spectroscopy measurements. Both tumor bearing-groups had higher mean PpIX fluorescence
than the control group as can be seen in Figure 4(c), although the 9L-GFP group was only
slightly higher than the control group, explaining its lower sensitivity and specificity of
detection in vivo as compared to the U251 group (Figure 8(a)).
The variance in PpIX fluorescence following the administration of ALA seen in the 9L-GFP
tumor-bearing group via in vivo spectroscopy measurements was quite large in comparison to
the U251 tumor-bearing group or the control group (PpIX fluorescence standard deviation
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(SD): control SD = 1.64, 9L-GFP SD = 17.7, U251 SD = 9.45). A similar pattern of variance
was seen in the ex vivo spectroscopy measurements where the 9L-GFP group had a larger
standard deviation than the U251 group, which was slightly larger than the standard deviation
of the control group (PpIX fluorescence SD: control SD = 1.1, 9L-GFP SD = 3.5, U251 SD =
1.9). The varied ability of the 9L-GFP tumors to produce PpIX fluorescence could be explained
when the PpIX production pattern of the tissue was examined in comparison to the GFP
fluorescence and H+E stained section. Figure 5(a) showed the pattern of PpIX fluorescence
which was expected prior to examination of the 9L-GFP tumor-bearing group ex vivo. The
PpIX fluorescence was confined to the bulk tumor tissue, which could be seen when the PpIX
fluorescence images were compared to both the GFP fluorescence images and the
corresponding H+E images. However, many of the mice in the 9L-GFP group had a PpIX
production pattern more like that illustrated in Figure 5(b) and (c), where the PpIX fluorescence
in the bulk tumor was similar to that in surrounding normal brain, and increased production of
PpIX was only visible in the periphery of the tumor. These two different production patterns
would lead to high variability of PpIX fluorescence signal in vivo, as some tumor-bearing mice
in the 9L-GFP group would appear to have high PpIX fluorescence, when the entire tumor
produced PpIX (figure 5(a)), while other mice in the 9L-GFP group would appear to have
relatively low PpIX fluorescence, when only the periphery of the tumor produced PpIX (figure
5(b) and (c)).
The PpIX fluorescence standard deviation in the U251 tumor bearing group was considerably
smaller than in the 9L-GFP group by both in vivo and ex vivo spectroscopy measurements. As
can be seen in Figure 6, the PpIX production pattern in the U251 group was significantly
different from than in the 9L-GFP group. All of the mice in the U251 group showed extensive
PpIX production in the bulk tumor tissue and much higher PpIX signal in the tumor tissue over
the surrounding normal brain tissue. Thus, PpIX fluorescence signal detected via spectroscopy
was not as variable as that of the 9L-GFP group since all the U251 mice had PpIX production
which corresponded well to content of the brain tumor tissue. This decrease in PpIX production
heterogeneity of the U251 tumor model as compared to the 9L-GFP tumor model translated to
increased sensitivity and specificity of detection over the control animals (U251 AUC = 0.94,
9L-GFP AUC = 0.72).
Skin photobleaching was examined for its ability to increase PpIX contrast between tumor-
bearing mice and control mice. Due to the high PpIX production of the skin, the in vivo
spectroscopic measurements included PpIX produced in the brain tissue as well as PpIX
produced in the skin. Theoretically, photobleaching of skin PpIX fluorescence could increase
the difference in PpIX signal between control mice and tumor-bearing mice even though the
overall measured signal would be decreased. In the red light photobleaching experiment, the
average PpIX fluorescence following the administration of ALA, but prior to any skin
photobleaching was higher in the 9L-GFP tumor-bearing group than in the U251 tumor-bearing
group. However, the ex vivo spectroscopy measurements illustrated that the average PpIX
fluorescence of the U251 group was more than twice that of the 9L-GFP group. The PpIX
fluorescence measurements obtained during the time course of red light photobleaching were
considered to determine if the ability to quantify the average PpIX contained in the brain tumor
tissue was improved. As shown in Figure 7(d), after 8 minutes of red light photobleaching, a
similar relationship to that seen in the ex vivo data (Figure 4(c)) was visible by in vivo
spectroscopy measurements where the highest mean PpIX fluorescence was seen in the U251
group, followed by the 9L-GFP group and then the control group.
The sensitivity and specificity of detection as measured by AUC through ROC analysis were
decreased by the red light photobleaching as compared to 2 hours after ALA administration
but prior to any photobleaching. This decrease in sensitivity and specificity was due to
increased overlap of the PpIX fluorescence to transmittance ratio of the tumor-bearing animals
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and the control animals (U251 AUC = 0.92, 9L-GFP AUC = 0.69) (Figure 8(b)). Following
photobleaching the shape of the ROC curve for the 9L-GFP tumor-bearing animals was
significantly different from that prior to photobleaching (Figure 8). The sensitivity of detection
could be increased to 100% after photobleaching although; at this level of sensitivity to tumor
presence the specificity of detection was significantly decreased and caused detection of false
positives. Skin photobleaching was advantageous in the detection of the 9L-GFP tumors
because due to the 9L-GFP tumor PpIX production heterogeneity, 100% sensitivity in detection
of these tumors was not possible without photobleaching. In the case where tumor PpIX
production was heterogenous and tumor detection was of most importance, skin
photobleaching would be advantageous due to its ability to increase sensitivity to tumor
presence. In contrast, when specificity was most important skin photobleaching would not be
advantageous as it significantly decreased the specificity of detection for the 9L-GFP tumor-
bearing group.
CONCLUSIONS
In conclusion, noninvasive PpIX spectroscopy measurements were able to detect the presence
of both the 9L-GFP tumors and U251 tumors over non-tumor-bearing mice using the average
PpIX fluorescence of each group as the metric. The variance in PpIX production was quite
large in the 9L-GFP tumor-bearing group when compared to the U251 group or the control
group. This PpIX production difference can be explained through tumor tissue PpIX production
patterns, where some of the 9L-GFP tumors had high PpIX fluorescence in the bulk tumor
while other had increased PpIX fluorescence only in the periphery of the tumor with little
increase in PpIX fluorescence in the bulk tumor tissue. Red light skin photobleaching decreased
the contrast between the tumor-bearing groups and the control group but increased the ability
to quantify the PpIX fluorescence contained within the brain tissue over the PpIX fluorescence
in the skin. A noninvasive, low cost fluorescence based detection system has been demonstrated
to be useful for detection of brain tumor models although, sensitivity and specificity of
noninvasive detection of tumors is influenced by the PpIX production pattern of the model
tumor tissue. This system could potentially be extended to other laboratory tumor models
following ex vivo studies to confirm tumor burden corresponded to PpIX fluorescence intensity,
which appears to be model dependent.
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(a) A schematic of the single channel spectroscopy system is shown containing a 635 nm laser,
a spectrometer, a 650 nm LP filter and a computer. In (b) a photograph of the system with the
light tight box open is shown. In (c) a sample mouse is shown in the holder in position for
measurement.
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In (a) the PpIX fluorescence emission data is plotted for a sample mouse. In (b) the
transmittance spectrum from the 635 nm laser through the head of a sample mouse is shown.
In (c) the PpIX fluorescence data is spectrally fitted to a reference PpIX spectrum from tissue-
simulating phantom data. In (d) the deconvolved fluorescence and non-specific background
signals are shown.
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In (a) the rodent coil inside the 3T MRI is shown, and in (b) an example mouse in the rodent
coil with IP catheter for Gd-DTPA injection is shown. In (c) a sample set of T1 coronal turbo
spin echo contrast enhanced (TSE-CE) images are shown, for a 9L-GFP tumor.
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The PpIX fluorescence to transmittance signal ratio (F/T Ratio) (a) prior to ALA administration
in vivo, (b) 2 hours after ALA administration in vivo, and (c) 2 hours after ALA administration,
measured ex vivo on the extracted whole brain.
Gibbs-Strauss et al. Page 13














Images of mouse brain tissue with 9L-GFP tumors, showing GFP (1st row), PpIX (2nd row)
and H+E (3rd row) of the same sections of the brain. Also, in the bottom row, in vivo T1 turbo
spin echo contrast enhanced (TSE-CE) MRI of approximately the same section. In (a) the PpIX
fluorescence can be seen in bulk tumor as compared to the H+E stained image and the GFP
fluorescence image. In (b) and (c) the PpIX fluorescence was observed only at the periphery
of the tumor tissue, not in bulk tumor as can be seen by comparing the PpIX fluorescence image
with the corresponding H+E stained images and GFP fluorescence images.
Gibbs-Strauss et al. Page 14














Images of mouse brain tissue with U251 tumors shown with ex vivo PpIX fluorescence images
(1st row) and corresponding H+E stained images (2nd row) of the same sections of the brain.
In vivo T1 turbo spin echo contrast enhanced (TSE-CE) MRI (3rd row) and T2 TSE MR images
(4th row) of approximately the same section shown in ex vivo images. In (a) – (c) all mice
exhibit increased PpIX fluorescence corresponding to the bulk tumor area as compared to the
PpIX fluorescence of the surrounding normal brain tissues.
Gibbs-Strauss et al. Page 15














The PpIX fluorescence to transmittance ratio (F/T Ratio) of the mice in the control group and
each tumor-bearing group after (a) 1 minute, (b) 2 minutes, (c) 4 minutes and (d) 8 minutes of
red light photobleaching. The mean of the U251 group was higher than the mean of the 9L-
GFP group for the first time following ALA administration in the photobleaching time course
after 8 minutes of red light photobleaching.
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Receiver operator characteristic (ROC) curve for PpIX fluorescence to transmittance ratio of
U251 tumor-bearing group vs. control non-tumor-bearing group and 9L-GFP tumor-bearing
group vs. control group. The area under the curve (AUC) was calculated as a metric to compare
tumor detection sensitivity and specificity for the two tumor types over control, non-tumor-
bearing animals. The ROC curve for PpIX fluorescence tumor detection (a) 2 hours after ALA
administration where the U251 AUC = 0.94 and the 9L-GFP AUC = 0.72 and (b) after 8 minutes
of red light photobleaching where the U251 AUC = 0.92 and the 9L-GFP AUC = 0.69.
Gibbs-Strauss et al. Page 17
J Biomed Opt. Author manuscript; available in PMC 2010 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
